AIP
ATRA icon

Ameritas Investment Partners’s Atara Biotherapeutics ATRA Stock Holding History

Ameritas Investment Partners’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-271
Closed -$4.71K – 3132
2024
Q1 		$4.71K Hold
271
– – ﹤0.01% 2956
2023
Q4 		$3.48K Hold
271
– – ﹤0.01% 3019
2023
Q3 		$10K Hold
271
– – ﹤0.01% 2835
2023
Q2 		$10.9K Hold
271
– – ﹤0.01% 2877
2023
Q1 		$19.7K Hold
271
– – ﹤0.01% 2474
2022
Q4 		$28.2K Hold
271
– – ﹤0.01% 2398
2022
Q3 		$25K Hold
271
– – ﹤0.01% 2401
2022
Q2 		$52K Hold
271
– – ﹤0.01% 1962
2022
Q1 		$63K Hold
271
– – ﹤0.01% 1924
2021
Q4 		$107K Buy
271
+24
+10% +$10.1K ﹤0.01% 1635
2021
Q3 		$110K Hold
247
– – ﹤0.01% 1629
2021
Q2 		$96K Hold
247
– – ﹤0.01% 1745
2021
Q1 		$89K Hold
247
– – ﹤0.01% 1741
2020
Q4 		$121K Hold
247
– – 0.01% 1457
2020
Q3 		$80K Buy
247
+44
+22% +$15K ﹤0.01% 1567
2020
Q2 		$74K Buy
203
+23
+13% +$5.81K ﹤0.01% 1596
2020
Q1 		$38K Hold
180
– – ﹤0.01% 1812
2019
Q4 		$74K Buy
180
+29
+19% +$10K ﹤0.01% 1674
2019
Q3 		$53K Hold
151
– – ﹤0.01% 1848
2019
Q2 		$76K Buy
151
+18
+14% +$12.7K ﹤0.01% 1670
2019
Q1 		$132K Hold
133
– – 0.01% 1292
2018
Q4 		$116K Hold
133
– – 0.01% 1279
2018
Q3 		$138K Hold
133
– – 0.01% 1336
2018
Q2 		$122K Buy
133
+22
+20% +$23.6K 0.01% 1398
2018
Q1 		$108K Buy
111
+39
+54% +$35.5K 0.01% 1433
2017
Q4 		$33K Hold
72
– – ﹤0.01% 2160
2017
Q3 		$28K Hold
72
– – ﹤0.01% 2223
2017
Q2 		$25K Hold
72
– – ﹤0.01% 2328
2017
Q1 		$37K Buy
+72
New +$29.8K ﹤0.01% 2030

Other funds holding ATRA

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Ameritas Investment Partners's ATRA Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Atara Biotherapeutics (ATRA) in Q2 2024, closing a stake of 271 shares — an estimated $4.71K sold.

Ameritas Investment Partners first reported a position in ATRA in Q1 2017 and held it in 29 quarters. The position peaked at $138K in Q3 2018. 48 funds tracked by Wall St. Rank hold ATRA as of Q2 2024.

  • Ameritas Investment Partners reported no remaining Atara Biotherapeutics position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 271 Atara Biotherapeutics shares in Q2 2024, an estimated $4.71K.
  • Ameritas Investment Partners first reported a position in Atara Biotherapeutics in Q1 2017 and held it in 29 quarters.
  • Ameritas Investment Partners's Atara Biotherapeutics position peaked at $138K in Q3 2018.
  • 48 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.